AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...

STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — Pitney Bowes Inc. (PBI) on Wednesday reported earnings of $52 million in its third quarter. On a per-share basis, the Stamford, Connecticut-based company ...

Oct 27 (Reuters) - BioMarin Pharmaceutical (BMRN.O), opens new tab said on Monday it plans to divest its gene therapy, a product once expected to be a blockbuster treatment for a type of rare bleeding ...

A few months after launching its lead gene therapy into the clinic, Arbor Biotechnologies has found a European partner to come along for the ride. Italian pharma Chiesi is fertilizing Arbor’s rare ...

In a deal that could bring more than $2.1 billion in payments to Arbor Biotechnologies Inc., 90-year-old Chiesi Group gained exclusive and global rights to develop and commercialize ABO-101 for ...

Bluebird bio has re-emerged after a private equity buyout as Genetix Biotherapeutics, marking a return to its roots and a new path forward for manufacturing. Bluebird bio is emerging from the other ...

BOSTON and SEOUL, South Korea, Aug. 26, 2025 /PRNewswire/ -- iNtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering ...

After telegraphing an investigation in November, the FDA has moved to restrict the use of bluebird bio’s gene therapy Skysona in certain patients. The FDA has updated Skysona’s indication, allowing it ...

A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies. His work was reviled as reckless and unethical because, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A St. Louis startup is ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Wilson, CEO of Gemma Bio, called ...